Filter posts

Greenwood Shines Spotlight on Insurance Industry Rip-off

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a …

Using Biotechnology to Tackle Deadly Mosquito-Borne Illnesses

Every year, nearly a million deaths are attributed to mosquito-borne illnesses and 500 million people …

Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innov...

In October of 2018, the Trump Administration outlined a proposal that would import foreign price …

The Right Way to Address Prescription Drug Costs

Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City …

BIO Illustrates the Success of the Orphan Drug Act

The numbers might surprise you. Approximately 7,000 rare diseases are known to exist, and approximately …

The Administration’s Orwellian Defense of Importing Foreign Price Controls

The Trump administration is out with a new blog post defending its plan to adopt …

Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio

During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks …

Think the Drug-Pricing debate addresses Patient Costs? Think again.

Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate …

Claims of Gene-Edited Twins Met with Criticism and Concern

As the Second International Summit on Human Genome Editing wraps in Hong Kong this week, breaking …

Alzheimer’s Awareness Month: Hope on the Horizon

Did you know that more than 5 million Americans are currently living with Alzheimer’s disease? …